Home » Topics » Regulatory

Regulatory
RSS

SmithKline Beecham claims 5-HT6 antagonists for ADHD

March 30, 2000

Organogenesis receives milestone payment related to Apligraf progress

March 30, 2000

Merck & Co. confirms study results of Singulair as allergic rhinitis treatment

March 29, 2000

Extensive review of novel cytoprotectant appears in supplementary issue of DOT

March 29, 2000

CPMP recommends approval of Kogenate Bayer as hemophilia A treatment

March 27, 2000

New study of Sandostatin for managing diarrhea to commence in the U.S. and Canada

March 27, 2000

Merck compound L-754030 and use in circadian rhythm disorders covered by new patent

March 23, 2000

Known antiallergic agent from Kyorin now claimed for use in MS

March 22, 2000

Oral Hectorol clinical progress updated

March 22, 2000

Dermagraft epicardial patch induces angiogenesis in preclinical studies

March 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...